Stockreport

NewAmsterdam Pharma Company (NAMS): Huge Upside Potential Grabs Attention of Billionaire Stan Druckenmiller [Yahoo! Finance]

enGene Holdings Inc.  (ENGN) 
PDF NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) is a relatively recent addition to the 13F portfolio of Duquesne Capital. The fund first disclosed a stake in the company [Read more]